December 2020 Half Year Highlights:
- Sales $4.1m - an improvement of 65% on 1H FY20
- Gross margin 35% - a gain of 158% on 1HFY20
- EBITDA loss $225,854 - a 92% improvement on 1HFY20
- New contracts secured - $3.6m
CEO Commentary
DXN has made significant progress with its restructuring and strategy implementation and the benefits began to emerge in 1HFY21. A strong focus on reducing operating expenses, improved gross margin (from 22% to 35%) and increased sales improved EBITDA by 92% compared to 1HFY20. We are seeing positive results with regards to cost containment and improved efficiencies being achieved at DXN’s new manufacturing facility.
Full Report
https://www.asx.com.au/asxpdf/20210218/pdf/44ssw7n5p2cs94.pdf